4,635 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Acquired by Cibc World Markets Corp

Cibc World Markets Corp bought a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,635 shares of the company’s stock, valued at approximately $362,000.

Other institutional investors have also added to or reduced their stakes in the company. Natixis Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 11.4% in the 3rd quarter. Natixis Advisors LLC now owns 14,581 shares of the company’s stock worth $1,051,000 after purchasing an additional 1,491 shares in the last quarter. Intech Investment Management LLC purchased a new stake in Prestige Consumer Healthcare in the third quarter worth about $620,000. Citigroup Inc. increased its position in Prestige Consumer Healthcare by 66.6% in the third quarter. Citigroup Inc. now owns 76,772 shares of the company’s stock worth $5,535,000 after buying an additional 30,677 shares in the last quarter. Cerity Partners LLC raised its stake in shares of Prestige Consumer Healthcare by 103.9% in the third quarter. Cerity Partners LLC now owns 6,347 shares of the company’s stock worth $458,000 after buying an additional 3,234 shares during the period. Finally, Horizon Kinetics Asset Management LLC lifted its position in shares of Prestige Consumer Healthcare by 4.8% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after buying an additional 150 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on PBH. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a research report on Monday, December 9th. Royal Bank of Canada lifted their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research note on Friday. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday, March 18th. Finally, Canaccord Genuity Group boosted their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $93.33.

Insider Activity

In other news, SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH opened at $85.46 on Tuesday. The company has a market cap of $4.23 billion, a P/E ratio of 20.01, a P/E/G ratio of 2.69 and a beta of 0.46. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm’s fifty day moving average is $82.67 and its two-hundred day moving average is $78.72.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.